|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 3/04/14 Mimedx Group, Inc. 10-K 12/31/13 81:10M |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 790K
2: EX-10.3 Material Contract HTML 33K
3: EX-10.4 Material Contract HTML 32K
4: EX-10.5 Material Contract HTML 31K
5: EX-23.1 Consent of Experts or Counsel HTML 22K
6: EX-31.1 Certification -- §302 - SOA'02 HTML 29K
7: EX-31.2 Certification -- §302 - SOA'02 HTML 29K
8: EX-32.1 Certification -- §906 - SOA'02 HTML 24K
9: EX-32.2 Certification -- §906 - SOA'02 HTML 24K
57: R1 Document and Entity Information HTML 50K
46: R2 Consolidated Balance Sheets HTML 124K
55: R3 Consolidated Balance Sheets (Parenthetical) HTML 49K
59: R4 Consolidated Statements of Operations HTML 81K
75: R5 Consolidated Statements of Stockholders' Equity HTML 151K
48: R6 Consolidated Statements of Stockholders' Equity HTML 25K
(Parenthetical)
54: R7 Consolidated Statements of Cash Flows HTML 156K
42: R8 Consolidated Statements of Cash Flows HTML 24K
(Parenthetical)
32: R9 Nature of Business HTML 26K
76: R10 Significant Accounting Policies HTML 62K
61: R11 Liquidity and Management's Plans HTML 24K
60: R12 Inventories HTML 37K
66: R13 Property and Equipment HTML 41K
67: R14 Intangible Assets and Royalty Agreement HTML 66K
64: R15 Long-Term Debt HTML 47K
68: R16 Net Income (loss) Per Share HTML 56K
56: R17 Common Stock Placements HTML 38K
58: R18 Equity HTML 218K
63: R19 Income Taxes HTML 64K
81: R20 Supplemental Disclosure of Cash Flow and Non-Cash HTML 69K
Investing and Financing Activities
71: R21 Related Party Transactions HTML 47K
51: R22 401k Plan HTML 33K
62: R23 Commitments and Contingencies HTML 42K
53: R24 Quarterly Financial Data (Unaudited) HTML 80K
25: R25 Schedule II - Valuation and Qualifying Accounts HTML 57K
(Notes)
72: R26 Significant Accounting Policies (Policies) HTML 157K
78: R27 Inventories (Tables) HTML 35K
37: R28 Property and Equipment (Tables) HTML 38K
36: R29 Intangible Assets and Royalty Agreement (Tables) HTML 65K
40: R30 Long-Term Debt (Tables) HTML 40K
41: R31 Net Income (loss) Per Share (Tables) HTML 56K
43: R32 Equity (Tables) HTML 224K
23: R33 Income Taxes (Tables) HTML 57K
69: R34 Supplemental Disclosure of Cash Flow and Non-Cash HTML 66K
Investing and Financing Activities (Tables)
50: R35 Related Party Transactions (Tables) HTML 43K
52: R36 Commitments and Contingencies (Tables) HTML 30K
28: R37 Quarterly Financial Data (Unaudited) (Tables) HTML 77K
80: R38 Nature of Business (Details) HTML 24K
17: R39 Significant Accounting Policies (Details) HTML 61K
44: R40 Liquidity and Management's Plans (Details) HTML 34K
74: R41 Inventories (Details) HTML 40K
27: R42 Property and Equipment (Details) HTML 43K
35: R43 Intangible Assets and Royalty Agreement (Details) HTML 132K
39: R44 Long-Term Debt (Schedule of Debt Instruments) HTML 37K
(Details)
47: R45 Long-Term Debt (Details) HTML 83K
22: R46 Net Income (loss) Per Share (Details) HTML 73K
31: R47 Common Stock Placements (Details) HTML 37K
19: R48 Equity (Narrative) (Details) HTML 42K
73: R49 Equity (Activity of Stock Options) (Details) HTML 86K
26: R50 Equity (Exercise Price Ranges) (Details) HTML 63K
70: R51 Equity (Summary of Unvested Stock Options) HTML 41K
(Details)
29: R52 Equity (Assumptions) (Details) HTML 38K
45: R53 Equity (Summary of Restricted Stock Awards) HTML 63K
(Details)
18: R54 Equity (Recognized Stock-Based Compensation) HTML 30K
(Details)
21: R55 Equity (Warrants) (Details) HTML 71K
38: R56 Income Taxes (Details) HTML 90K
24: R57 Supplemental Disclosure of Cash Flow and Non-Cash HTML 93K
Investing and Financing Activities (Details)
77: R58 Related Party Transactions (Details) HTML 36K
49: R59 401k Plan (Details) HTML 35K
65: R60 Commitments and Contingencies (Details) HTML 40K
30: R61 Quarterly Financial Data (Unaudited) (Details) HTML 43K
33: R62 Schedule II - Valuation and Qualifying Accounts HTML 35K
(Details)
79: XML IDEA XML File -- Filing Summary XML 114K
20: EXCEL IDEA Workbook of Financial Reports XLSX 204K
34: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 1.48M
10: EX-101.INS XBRL Instance -- mdxg-20131231 XML 2.43M
12: EX-101.CAL XBRL Calculations -- mdxg-20131231_cal XML 199K
13: EX-101.DEF XBRL Definitions -- mdxg-20131231_def XML 511K
14: EX-101.LAB XBRL Labels -- mdxg-20131231_lab XML 1.82M
15: EX-101.PRE XBRL Presentations -- mdxg-20131231_pre XML 918K
11: EX-101.SCH XBRL Schema -- mdxg-20131231 XSD 178K
16: ZIP XBRL Zipped Folder -- 0001376339-14-000005-xbrl Zip 249K
| MDXG - 2013.12.31 - 10-K Ex. 31.1 |
1. | I have reviewed this annual report on Form 10-K of MiMedx Group, Inc.; |
2. | Based on my knowledge,
this annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this annual report; |
3. | Based on my knowledge, the financial statements, and other financial information included in this annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this annual report; |
4. | The
registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
(a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries,
is made known to us by others within those entities, particularly during the period in which this annual report is being prepared, |
(b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles, |
(c) | evaluated the effectiveness of the
registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this annual report based on such evaluation, and |
(d) | disclosed in this annual report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth quarter in the case of an annual report) that
has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent
function): |
(a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
(b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the
registrant’s internal control over financial reporting. |
/s/: Parker H. Petit | ||
Parker H. Petit | ||
Chief
Executive Officer | ||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/4/14 | |||
| For Period end: | 12/31/13 | 10-K/A | ||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 2/28/24 Mimedx Group, Inc. 10-K 12/31/23 116:11M 2/28/23 Mimedx Group, Inc. 10-K 12/31/22 123:13M 2/28/22 Mimedx Group, Inc. 10-K 12/31/21 112:13M 3/08/21 Mimedx Group, Inc. 10-K 12/31/20 111:12M |